EBS signs licensing deal in China

EBS signs licensing deal in China

EBS aims to take cataract treatment from the operating theatre to the high street as company signs licensing deal in China – Licensing and equity investment deal with China’s Haoguang Bio-tech, a wholly owned subsidiary of Boye Biotech – EBS has raised around £3m to date and is about to embark on a £5m series […]